Organization Profile

You just read:

Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen™ in AGHD

News provided by

Aeterna Zentaris Inc.

Jun 25, 2015, 07:30 ET